Promoter hypermethylation contributes to the frequent suppression of the CDK10 gene in human nasopharyngeal carcinomas

Cellular Oncology

Volumn 36, Issue 4, 2013, Pages 323-331

  You, Yanjie ^a   Yang, Wenjun ^b   Wang, Zhizhong ^b   Zhu, Huimin ^c   Li, Haijun ^d   Lin, Canfeng ^e   Ran, Yonggang ^f  

^a Luohe Medical College   (China)

^b NINGXIA MEDICAL UNIVERSITY   (China)

^c Third Affiliated Hospital of Luohe Medical College   (China)

^d The First People's Hospital of Neijiang   (China)

^e SHANTOU CENTRAL HOSPITAL   (China)

^f Bethune Military Medical College   (China)

Author keywords

Cancer surveillance and screening; CDK10; DNA methylation; Nasopharyngeal carcinoma; Tumor suppressor gene

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 10; UNCLASSIFIED DRUG;

ARTICLE; BISULFITE SEQUENCING; BLOOD SAMPLING; CANCER CELL CULTURE; CANCER INHIBITION; CELL PROLIFERATION; CLINICAL ARTICLE; COLONY FORMATION; CONTROLLED STUDY; DEMETHYLATION; DNA METHYLATION; DOWN REGULATION; FLOW CYTOMETRY; GENE EXPRESSION; GENE REPRESSION; GENE SEQUENCE; GENETIC MARKER; HUMAN; HUMAN CELL; METHYLATION SPECIFIC POLYMERASE CHAIN REACTION; NASOPHARYNX CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER HYPERMETHYLATION; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHINOPHARYNGITIS; SENSITIVITY AND SPECIFICITY; TUMOR INVASION; WESTERN BLOTTING;

EID: 84881629263     PISSN: 22113428     EISSN: 22113436     Source Type: Journal    
DOI: 10.1007/s13402-013-0137-5     Document Type: Article

References (22)

1. G. Niedobitek, Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma. Mol. Pathol. 53, 248-54 (2000)
2. G. Sanguineti, F.B. Geara, A.S. Garden, S.L. Tucker, K.K. Ang, W.H. Morrison, L.J. Peters, Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of local and regional control. Int. J. Radiat. Oncol. Biol. Phys. 37, 985-96 (1997)
3. X. Graña, P.P. Claudio, A. De Luca, N. Sang, A. Giordano, PISSLRE, a human novel CDC2-related protein kinase. Oncogene 9, 2097-2103 (1994)
4. R. Brambilla, G. Draetta, Molecular cloning of PISSLRE, a novel putative member of the cdk family of protein serine/threonine kinases. Oncogene 9, 3037-3041 (1994)
5. F. Bullrich, T.K. MacLachlan, N. Sang, T. Druck, M.L. Veronese, S.L. Allen, N. Chiorazzi, A. Koff, K. Heubner, C.M. Croce et al., Chromosomal mapping of members of the cdc2 family of protein kinases, cdk3, cdk6, PISSLRE, and PITALRE, and a cdk inhibitor, p27Kip1, to regions involved in human cancer. Cancer Res. 55, 1199-1205 (1995)
6. J. Crawford, L. Ianzano, M. Savino, S. Whitmore, A.M. Cleton-Jansen, C. Settasatian, M. d'apolito, R. Seshadri, J.C. Pronk, A.D. Auerbach, P.C. Verlander, C.G. Mathew, A.J. Tipping, N.A. Doggett, L. Zelante, D.F. Callen, A. Savoia, The PISSLRE gene: Structure, exon skipping, and exclusion as tumor suppressor in breast cancer. Genomics 56, 90-97 (1999)
7. J.H. Yu, X.Y. Zhong, W.G. Zhang, Z.D. Wang, Q. Dong, S. Tai, H. Li, Y.F. Cui, CDK10 functions as a tumor suppressor gene and regulates survivability of biliary tract cancer cells. Oncol Rep. 27, 1266-1276 (2012)
8. X.Y. Zhong, X.X. Xu, J.H. Yu, G.X. Jiang, Y. Yu, S. Tai, Z.D. Wang, Y.F. Cui, Clinical and biological significance of Cdk10 in hepatocellular carcinoma. Gene 498, 68-74 (2012)
9. M. Guo, J. Ren, M.V. Brock, J.G. Herman, H.E. Carraway, Promoter methylation of HIN-1 in the progression to esophageal squamous cancer. Epigenetics. 3, 336-41 (2008)
10. Y.H. Baek, E. Chang, Y.J. Kim, B.K. Kim, J.H. Sohn, D.I. Park, Stool methylation-specific polymerase chain reaction assay for the detection of colorectal neoplasia in Korean patients. Dis. Colon Rectum 52, 1452-1459 (2009)
11. Y.K. Bae, Y.R. Shim, J.H. Choi, M.J. Kim, E. Gabrielson, S.J. Lee, T.Y. Hwang, S.O. Shin, Gene promoter hypermethylation in tumors and plasma of breast cancer patients. Cancer Res. Treat. 37, 233-240 (2005)
12. W. Zhu, W. Qin, J.E. Hewett, E.R. Sauter, Quantitative evaluation of DNA hypermethylation in malignant and benign breast tissue and fluids. Int. J. Cancer 126, 474-482 (2010)
13. Y. Ran, S. Wu, Y. You, Demethylation of E-cadherin gene in nasopharyngeal carcinoma could serve as a potential therapeutic strategy. J. Biochem. 149, 49-54 (2011)
14. E. Iorns, N.C. Turner, R. Elliott, N. Syed, O. Garrone, M. Gasco, A.N. Tutt, T. Crook, C.J. Lord, A. Ashworth, Identification of CDK10 as an important determinant of resistance to endocrine therapy for breast cancer. Cancer Cell. 13, 91-104 (2008)
15. S.A. Ahrendt, J.T. Chow, L.H. Xu, S.C. Yang, C.F. Eisenberger, M. Esteller, J.G. Herman, L. Wu, P.A. Decker, J. Jen, D. Sidransky, Molecular detection of tumor cells in bronchoalveolar lavage fluid from patients with early stage lung cancer. J Natl Cancer Inst 91, 332-339 (1999)
16. S.L. Rosas, W. Koch, M.G. da Costa Carvalho, L. Wu, J. Califano, W. Westra, J. Jen, D. Sidransky, Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients. Cancer Res. 61, 939-942 (2001)
17. D. Sun, Z. Zhang, N. Van do, G. Huang, I. Ernberg, L. Hu, Aberrant methylation of CDH13 gene in nasopharyngeal carcinoma could serve as a potential diagnostic biomarker. Oral Oncol 43, 82-87 (2007)
18. A.C. Hoffmann, D. Vallböhmer, K. Prenzel, R. Metzger, M. Heitmann, S. Neiss, F. Ling, A.H. Hölscher, P.M. Schneider, J. Brabender, Methylated DAPK and APC promoter DNA detection in peripheral blood is significantly associated with apparent residual tumor and outcome. J. Cancer Res. Clin. Oncol. 135, 1231-1237 (2009)
19. Y. You, X. Xue, M. Li, X. Qin, C. Zhang, W. Wang, C. Jiang, S. Wu, Y. Liu, W. Zhu, Y. Ran, Z. Zhang, W. Han, Y. Zhang, Inhibition effect of pcDNA-tum-5 on the growth of S180 tumor. Cytotechnology 56, 97-104 (2008)
20. G. Heller, B. Ziegler, A. Brandstetter, S. Novak, M. Rudas, G. Hennig, M. Gehrmann, T. Acht, S. Zöchbauer-Müller, M. Filipits, CDK10 is not a target for aberrant DNA methylation in breast cancer. Anticancer. Res. 29, 3939-3944 (2009)
21. H.W. Chang, A. Chan, D.L. Kwong, W.I. Wei, J.S. Sham, A.P. Yuen, Evaluation of hypermethylated tumor suppressor genes as tumor markers in mouth and throat rinsing fluid, nasopharyngeal swab and peripheral blood of nasopharygeal carcinoma patient. Int. J. Cancer 105, 851-855 (2003)
22. Y.J. You, Y.P. Chen, X.X. Zheng, S.J. Meltzer, H. Zhang, Aberrant methylation of the NPC gene in peripheral blood as a potential biomarker in esophageal squamous cell carcinoma patients. Cancer Lett. 315, 138-144 (2012)